Literature DB >> 28592904

Non-motor features of Parkinson disease.

Anthony H V Schapira1, K Ray Chaudhuri2, Peter Jenner3.   

Abstract

Many of the motor symptoms of Parkinson disease (PD) can be preceded, sometimes for several years, by non-motor symptoms that include hyposmia, sleep disorders, depression and constipation. These non-motor features appear across the spectrum of patients with PD, including individuals with genetic causes of PD. The neuroanatomical and neuropharmacological bases of non-motor abnormalities in PD remain largely undefined. Here, we discuss recent advances that have helped to establish the presence, severity and effect on the quality of life of non-motor symptoms in PD, and the neuroanatomical and neuropharmacological mechanisms involved. We also discuss the potential for the non-motor features to define a prodrome that may enable the early diagnosis of PD.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28592904     DOI: 10.1038/nrn.2017.62

Source DB:  PubMed          Journal:  Nat Rev Neurosci        ISSN: 1471-003X            Impact factor:   34.870


  253 in total

Review 1.  Nonmotor symptoms in genetic Parkinson disease.

Authors:  Meike Kasten; Lena Kertelge; Norbert Brüggemann; Joyce van der Vegt; Alexander Schmidt; Vera Tadic; Carsten Buhmann; Susanne Steinlechner; Maria Isabel Behrens; Alfredo Ramirez; Ferdinand Binkofski; Hartwig Siebner; Heiner Raspe; Johann Hagenah; Rebekka Lencer; Christine Klein
Journal:  Arch Neurol       Date:  2010-06

2.  Visual symptoms in Parkinson's disease and Parkinson's disease dementia.

Authors:  Neil K Archibald; Mike P Clarke; Urs P Mosimann; David J Burn
Journal:  Mov Disord       Date:  2011-09-27       Impact factor: 10.338

Review 3.  Integrative control of the lower urinary tract: preclinical perspective.

Authors:  William C de Groat
Journal:  Br J Pharmacol       Date:  2006-02       Impact factor: 8.739

4.  Factors associated with depression in Parkinson's disease.

Authors:  Nadeeka N W Dissanayaka; Anna Sellbach; Peter A Silburn; John D O'Sullivan; Rodney Marsh; George D Mellick
Journal:  J Affect Disord       Date:  2011-02-26       Impact factor: 4.839

5.  Parkinson's disease symptoms: the patient's perspective.

Authors:  Marios Politis; Kit Wu; Sophie Molloy; Peter G Bain; K Ray Chaudhuri; Paola Piccini
Journal:  Mov Disord       Date:  2010-08-15       Impact factor: 10.338

6.  Neurochemical plasticity in the enteric nervous system of a primate animal model of experimental Parkinsonism.

Authors:  T Chaumette; T Lebouvier; P Aubert; B Lardeux; C Qin; Q Li; D Accary; E Bézard; S Bruley des Varannes; P Derkinderen; M Neunlist
Journal:  Neurogastroenterol Motil       Date:  2008-12-05       Impact factor: 3.598

7.  Dopaminergic mechanisms underlying bladder hyperactivity in rats with a unilateral 6-hydroxydopamine (6-OHDA) lesion of the nigrostriatal pathway.

Authors:  Naoki Yoshimura; Sadako Kuno; Michael B Chancellor; William C De Groat; Satoshi Seki
Journal:  Br J Pharmacol       Date:  2003-08       Impact factor: 8.739

Review 8.  Therapeutic prospects for Parkinson disease.

Authors:  C Warren Olanow; Anthony H V Schapira
Journal:  Ann Neurol       Date:  2013-09       Impact factor: 10.422

9.  Apathy following subthalamic stimulation in Parkinson disease: a dopamine responsive symptom.

Authors:  Virginie Czernecki; Michael Schüpbach; Sadek Yaici; Richard Lévy; Eric Bardinet; Jérôme Yelnik; Bruno Dubois; Yves Agid
Journal:  Mov Disord       Date:  2008-05-15       Impact factor: 10.338

10.  Sleep dysfunction and EEG alterations in mice overexpressing alpha-synuclein.

Authors:  Kimberly A McDowell; David Shin; Kenneth P Roos; Marie-Françoise Chesselet
Journal:  J Parkinsons Dis       Date:  2014       Impact factor: 5.568

View more
  320 in total

1.  Dynamics of device-based treatments for Parkinson's disease in Germany from 2010 to 2017: application of continuous subcutaneous apomorphine, levodopa-carbidopa intestinal gel, and deep brain stimulation.

Authors:  Daniel Richter; Dirk Bartig; Wolfgang Jost; Christoph Jörges; Britta Stumpe; Ralf Gold; Christos Krogias; Lars Tönges
Journal:  J Neural Transm (Vienna)       Date:  2019-06-20       Impact factor: 3.575

2.  Sex-related differences in olfactory function and evaluation of possible confounding factors among patients with Parkinson's disease.

Authors:  P Solla; C Masala; A Liscia; R Piras; T Ercoli; L Fadda; T Hummel; A Haenher; G Defazio
Journal:  J Neurol       Date:  2019-09-25       Impact factor: 4.849

3.  Cross-cultural adaptation and psychometric properties of the SCOPA-Sleep-German version.

Authors:  Simone Goebel; Elisabeth Steinmann; Bernd Leplow; H Maximilian Mehdorn
Journal:  Neurol Sci       Date:  2018-04-14       Impact factor: 3.307

Review 4.  Nitric oxide signalling in the brain and its control of bodily functions.

Authors:  Konstantina Chachlaki; Vincent Prevot
Journal:  Br J Pharmacol       Date:  2019-09-08       Impact factor: 8.739

Review 5.  The A1 astrocyte paradigm: New avenues for pharmacological intervention in neurodegeneration.

Authors:  Jared T Hinkle; Valina L Dawson; Ted M Dawson
Journal:  Mov Disord       Date:  2019-05-28       Impact factor: 10.338

Review 6.  Role of adenosine A2A receptors in motor control: relevance to Parkinson's disease and dyskinesia.

Authors:  Annalisa Pinna; Marcello Serra; Micaela Morelli; Nicola Simola
Journal:  J Neural Transm (Vienna)       Date:  2018-02-02       Impact factor: 3.575

7.  Changes to Ventilation, Vocalization, and Thermal Nociception in the Pink1-/- Rat Model of Parkinson's Disease.

Authors:  Rebecca A Johnson; Cynthia A Kelm-Nelson; Michelle R Ciucci
Journal:  J Parkinsons Dis       Date:  2020       Impact factor: 5.568

Review 8.  Olfactory Dysfunction in Neurodegenerative Diseases.

Authors:  Concepció Marin; Dolores Vilas; Cristóbal Langdon; Isam Alobid; Mauricio López-Chacón; Antje Haehner; Thomas Hummel; Joaquim Mullol
Journal:  Curr Allergy Asthma Rep       Date:  2018-06-15       Impact factor: 4.806

9.  Dopamine transporter availability reflects gastrointestinal dysautonomia in early Parkinson disease.

Authors:  Jared T Hinkle; Kate Perepezko; Kelly A Mills; Zoltan Mari; Ankur Butala; Ted M Dawson; Alexander Pantelyat; Liana S Rosenthal; Gregory M Pontone
Journal:  Parkinsonism Relat Disord       Date:  2018-08-22       Impact factor: 4.891

10.  Early-onset Parkinsonian behaviors in female Pink1-/- rats.

Authors:  Julia M Marquis; Samantha E Lettenberger; Cynthia A Kelm-Nelson
Journal:  Behav Brain Res       Date:  2019-09-19       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.